Yeast Genetics and Molecular Biology 2000
University of Washington
Seattle, Washington USA
July 2000


Name: Loewith, Robbie
Mailing Address: Biochemistry & Molecular Biol, University of Calgary, 3330 Hospital Dr. NW, Calgary, AB T2N 4N1, Canada
Email Address: rjloewit@ucalgary.ca
Phone & FAX numbers: 403-220-8694 & 403-283-8727

#028

Yng2, a yeast homolog of the human candidate tumor suppressor Ing1, is a key component of the NuA4 histone acetyltransferase complex.
Robbie Loewith, Maria Meijer, Dallan Young
Biochemistry & Molecular Biol, University of Calgary, 3330 Hospital Dr. NW, Calgary, AB T2N 4N1, Canada

Three S. cerevisiae proteins (Yng1, Yng2, and Pho23) and two S. pombe proteins (Png1 and Png2) share significant sequence identity with the human candidate tumor suppressor Ing1 in their C-terminal regions. The homologous regions contain PHD finger domains which have been implicated in chromatin-mediated transcriptional regulation. We have shown that GFP-Yng2, like human Ing1, is localized in the nucleus. Deletion of YNG2 results in several phenotypes, including an abnormal multi-budded morphology, an inability to utilize non-fermentable carbon sources, heat-shock sensitivity, slow growth, temperature sensitivity, and sensitivity to caffeine. These phenotypes are suppressed by expression of either human Ing1 or S. pombe Png1. Yng1 and Pho23 deficient cells also share some of these phenotypes. We demonstrated by yeast two-hybrid and coimmunoprecipitation tests that Yng2 interacts with Tra1, a component of histone acetyltransferase (HAT) complexes. We further demonstrated by coimmunoprecipitation that HA-Yng1, HA-Yng2, HA-Pho23, and HA-Ing1 are associated with HAT activities in yeast. Genetic and biochemical evidence indicate that the Yng2-associated HAT is Esa1, suggesting that Yng2 is a component of the NuA4 HAT complex. These studies suggest that the yeast Ing1 related proteins are involved in chromatin remodeling. They further suggest that these functions may be conserved in mammals, and provide a possible mechanism for the human Ing1 candidate tumor suppressor.


Return to YGM 2000 Abstract Index